The Defiance Daily Target 2X Long MRNA ETF (MRNX) provides investors with amplified long exposure to Moderna, Inc. (NASDAQ: MRNA), a biotechnology company focused on the development and commercialization of messenger RNA (mRNA)–based medicines and vaccines. Moderna’s proprietary mRNA platform enables the rapid design and production of therapies across a range of disease areas, including infectious diseases and other unmet medical needs.
This ETF provides synthetic exposure. It does not hold the securities of the index directly so we cannot display its exposure breakdown.